Decoding molecular, clinico-pathological, and outcome differences between early-onset (EO, <50 years) and late-onset (LO, ≥50 years) mismatch repair deficient (dMMR)/microsatellite instability-high (MSI-H) colorectal cancer (CRC): Insights from real-world data.

Read full text
Authors: Michela Bartolini, Yasmine Baca, Rituparna Ganguly, David de Semir, Francesca Battaglin, Yan Yang, Sneha Soni, Pooja Mittal, Sandra Algaze, Unnati Hemant Shah, Lesly Torres-Gonzalez, Andrew Elliott
+5 more Rachna T. Shroff, Joshua Millstein, Wu Zhang, Alberto Puccini, Heinz-Josef Lenz
Cited by: 1

Abstract

19 Background: The incidence of EO CRC is rising globally. While clinico-molecular features of EO mismatch repair proficient/microsatellite stable CRC have been described, less is known about EO dMMR/MSI-H tumors, which are highly immunogenic and may represent a biologically distinct subset. This study provides a comprehensive comparison of EO versus LO dMMR/MSI-H CRC. Methods: We retrospectively analyzed CRC samples profiled by next-generation sequencing (NGS) of DNA/RNA and immunohistochemistry (IHC) at a CLIA-certified lab (Caris Life Sciences; Phoenix, AZ). Patients (pts) with confirmed dMMR/MSI-H CRC were stratified into EO and LO cohorts. Consensus Molecular Subtypes (CMS) were determined from RNA expression profiles using a 600-gene classifier. Statistical comparisons used chi-square, Fisher’s exact or Mann-Whitney U tests with multiple-testing correction (q

Fields of Study & Subjects

Genetic factors in colorectal cancer Ferroptosis and cancer prognosis Multiple and Secondary Primary Cancers

Publication details

Journal / source
Journal of Clinical Oncology
Publisher
American Society of Clinical Oncology (ASCO)
Volume
44
Issue
2_suppl
Pages
19–19
Publication date
10 January 2026
Language
EN